Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2543705 | 0.84 | EPHX1 (0.34) | SMN1; SMN2NPSR1CYP1A2CYP2D6PKM | |
| SCHEMBL2881080 | 0.82 | LMNA (0.33) | SMN1; SMN2NPSR1CYP1A2CYP2D6PKM | |
| SCHEMBL30007259 | 0.82 | CYP2D6 (0.32) | SMN1; SMN2NPSR1CYP1A2CYP2D6PKM | |
| SCHEMBL3859970 | 0.81 | CYP1A2 (0.33) | SMN1; SMN2NPSR1CYP1A2CYP2D6PKM | |
| SCHEMBL18662217 | 0.78 | HRH1 (0.41) | CYP1A2CYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL14213818 | 0.77 | CYP2C19 (0.41) | SMN1; SMN2NPSR1CYP1A2CYP2D6PKM | |
| SCHEMBL2100574 | 0.77 | TSHR (0.34) | SMN1; SMN2NPSR1CYP1A2CYP2D6PKM | |
| SCHEMBL2220085 | 0.77 | LMNA (0.38) | CYP2D6SLC6A2SLC6A4SLC6A3TSHR | |
| SCHEMBL2101611 | 0.76 | TSHR (0.37) | SMN1; SMN2NPSR1CYP1A2CYP2D6PKM | |
| SCHEMBL5598365 | 0.75 | TSHR (0.48) | SMN1; SMN2NPSR1CYP1A2CYP2D6PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 439 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022511-A1 | CARBON FIBERS WITH SURFACE MODIFICATION | DREXEL UNIVERSITY (US) | 2026-01-22 | — | — | US | claimed |
| US-12435465-B2 | High throughput carbon fiber surface modification | DREXEL UNIVERSITY (US) | 2025-10-07 | — | — | US | claimed |
| US-20250033988-A1 | SYNTHESIS, CAPPING AND DISPERSION OF HIGH REFRACTIVE INDEX NANOCRYSTALS AND NANOCOMPOSITES | PIXELLIGENT TECHNOLOGIES LLC | 2025-01-30 | — | — | US | claimed |
| EP-4453290-A1 | SYNTHESIS, CAPPING AND DISPERSION OF HIGH REFRACTIVE INDEX NANOCRYSTALS AND NANOCOMPOSITES | PT SPE SubCo LLC (US) | 2024-10-30 | — | — | EP | claimed |
| CN-118765339-A | Synthesis, capping and dispersion of high refractive index nanocrystals and nanocomposite materials | PT SPE塞博康有限责任公司 | 2024-10-11 | — | — | CN | claimed |
| CN-118562039-A | Preparation method of 3D bicontinuous hydrophilic polystyrene monolithic column | 中国石油大学(华东) | 2024-08-30 | — | — | CN | claimed |
| WO-2023122108-A1 | SYNTHESIS, CAPPING AND DISPERSION OF HIGH REFRACTIVE INDEX NANOCRYSTALS AND NANOCOMPOSITES | PIXELLIGENT TECHNOLOGIES LLC (US) | 2023-06-29 | — | — | WO | claimed |
| CN-111118882-B | Ultraviolet-proof fabric | 张昌录 | 2022-09-09 | — | — | CN | claimed |
| US-20220205166-A1 | HIGH THROUGHPUT CARBON FIBER SURFACE MODIFICATION | DREXEL UNIVERSITY (US) | 2022-06-30 | — | — | US | claimed |
| CN-113927991-A | Multilayer composite corrugated board and application thereof in preparation of corrugated box | 连云港市申润包装材料有限公司 | 2022-01-14 | — | — | CN | claimed |
| US-20070267349-A1 | METHOD OF SEPARATING COMPONENTS IN A SAMPLE USING SILANE-TREATED SILICA FILTER MEDIA | DOW CORNING CORPORATION | 2007-11-22 | — | — | US | claimed |
| CN-101076261-A | Method of preventing or reducing off-flavor in a beverage using silane-treated silica filter media | DOW CORNING (US) | 2007-11-21 | — | — | CN | claimed |
| EP-1838173-A2 | METHOD OF PREVENTING OR REDUCING OFF-FLAVOR IN A BEVERAGE USING SILANE-TREATED SILICA FILTER MEDIA | DOW CORNING CORPORATION (US) | 2007-10-03 | — | — | EP | claimed |
| EP-1737551-A2 | METHOD OF SEPARATING COMPONENTS IN A SAMPLE USING SILANE-TREATED SILICA FILTER MEDIA | GENENCOR INTERNATIONAL, INC. (US) | 2007-01-03 | — | — | EP | claimed |
| EP-1737305-A2 | METHOD OF PREVENTING OR REDUCING HAZE IN A BEVERAGE USING SILANE-TREATED SILICA FILTER MEDIA | GENENCOR INTERNATIONAL, INC. (US) | 2007-01-03 | — | — | EP | claimed |
| WO-2006065556-A2 | METHOD OF PREVENTING OR REDUCING OFF-FLAVOR IN A BEVERAGE USING SILANE-TREATED SILICA FILTER MEDIA | DOW CORNING CORPORATION (US) | 2006-06-22 | — | — | WO | claimed |
| WO-2005117616-A9 | METHOD OF PREVENTING OR REDUCING HAZE IN A BEVERAGE USING SILANE-TREATED SILICA FILTER MEDIA | GENENCOR INT (US) | 2006-05-04 | — | — | WO | claimed |
| WO-2005117616-A2 | METHOD OF PREVENTING OR REDUCING HAZE IN A BEVERAGE USING SILANE-TREATED SILICA FILTER MEDIA | GENENCOR INTERNATIONAL, INC. (US) | 2005-12-15 | — | — | WO | claimed |
| WO-2005115580-A2 | METHOD OF SEPARATING COMPONENTS IN A SAMPLE USING SILANE-TREATED SILICA FILTER MEDIA | GENENCOR INTERNATIONAL, INC. (US) | 2005-12-08 | — | — | WO | claimed |
| US-20050029195-A1 | Method of separating components in a sample using silane-treated silica filter media | DOW CORNING CORPORATION | 2005-02-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022511-A1 | CARBON FIBERS WITH SURFACE MODIFICATION | MACF1, COL2A1, COL1A1 | SMN1; SMN2 465/4885NPSR1 4629/4885CYP1A2 1905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.